Broadway Financial Regains Nasdaq Compliance, Resolving Listing Issue
BYFC sits 50% above its 52-week low of $5.51 on light trading volume (0.2× avg).
Summary
Broadway Financial Corporation announced it has regained compliance with Nasdaq listing rules following the timely filing of its Q3 2025 Form 10-Q, closing a potential delisting matter.
Key Events · Corporate Governance and Compliance · BYFC
-
Achieves Nasdaq Compliance
The company received a letter from Nasdaq confirming compliance with Listing Rule 5250(c)(1) based on its Q3 2025 Form 10-Q filing.
-
Delisting Matter Closed
Nasdaq has officially closed the matter related to the listing rule, removing a potential delisting threat.
-
Follows Recent Financial Filings
This compliance follows the recent filing of a 10-Q on February 13, 2026, which reported a significant net loss, and a prior restatement of Q1 2025 financials.
Analysis · BYFC · Finance
This 8-K is a positive development for Broadway Financial, as it confirms the company has resolved its compliance issue with Nasdaq Listing Rule 5250(c)(1). Given the recent history of a significant net loss and a prior financial restatement, the company likely faced scrutiny regarding its timely reporting. Achieving compliance removes a significant overhang and potential delisting risk, providing some stability amidst ongoing financial challenges. Investors should view this as a necessary step towards improving corporate governance and reducing regulatory uncertainty.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 36.9% of the 966 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.66%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BYFC was trading at $8.26 on NASDAQ in the Finance sector, with a market capitalization of approximately $75.8M. The 52-week trading range was $5.51 to $9.46. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.